Related Experiment Video
Updated: Jun 19, 2026

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
Published on: April 26, 2015
EXPERIMENTS ON THE CAUSATION AND AMELIORATION OF ADRENALIN PULMONARY EDEMA
1Department of Physiology and Pharmacology of The Rockefeller Institute for Medical Research.
Abstract:
The intratracheal injection of one moderate dose of adrenalin in rabbits whose vagi are divided produces a marked pulmonary edema in a large percentage of cases. The same dose in normal animals causes only slight effects. Artificial respiration greatly reduces the production of pulmonary edema in vagotomized rabbits after adrenalin. As adrenalin can exert a bronchoconstrictor effect, evidence is submitted to show that the aspirating action of the lung alveoli under this condition apparently plays an important part in the production of adrenalin pulmonary edema. On the basis of this mechanism the protective action of artificial respiration is explained. Stenosis of the trachea facilitates. the production of adrenalin pulmonary edema in rabbits whose vagi are intact. The intratracheal injection of adrenalin in vagotomized rabbits produces a temporary incoordination between the heart ventricles, visible on inspection, so that the left ventricle beats apparently half as fast as the right, causing hyperemia of the lungs and hemorrhages. Atropine injected intratracheally in vagotomized rabbits exerts a protective action against adrenalin pulmonary edema.
More Related Videos
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Pulmonary Edema II: Pathophysiology
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...

